NCT00040638已完成2 期
Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer
Telik6 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2002年7月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 6
研究概览
简要总结
The purpose of this study is to determine the effectiveness of TLK286 in the treatment of advanced non-small cell lung cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histologic or cytologic diagnosis of non-small cell lung carcinoma
- •Progressed while on or after treatment on platinum-based regimen
- •Patients may not have had more than one prior cytotoxic chemotherapy regimen
- •Stage IV or IIIB
- •Age at least 18 years
- •Adequate liver and kidney function
- •Adequate bone marrow function
排除标准
- •Pregnancy or lactation
- •Unstable medical conditions
- •Chemotherapy, hormonal therapy, radiotherapy, radiopharmaceuticals or immunotherapy within 3 weeks of TLK286
- •CNS metastasis unless controlled by treatment
研究者
研究点 (6)
Loading locations...
相似试验
已完成
1 期
Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung CancerCarcinoma, Non-small-cell LungNCT00047801Telik28
已完成
2 期
Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian CancerOvarian NeoplasmsNCT00038428Telik40
已完成
1 期
TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)Non-small Cell Lung CancerNCT00077883Telik50
已完成
3 期
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian CancerOvarian NeoplasmsNCT00057720Telik440
已完成
1 期
TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian CancerOvarian NeoplasmsNCT00051948Telik28